Early p53 alterations in mouse skin carcinogenesis by UVB radiation: immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells.
about
The relevance of the vitamin D endocrine system (VDES) for tumorigenesis, prevention, and treatment of non-melanoma skin cancer (NMSC): Present concepts and future perspectivesManganese superoxide dismutase is a mitochondrial fidelity protein that protects PolĪ³ against UV-induced inactivationPersistent p53 mutations in single cells from normal human skinMore epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine.Stochastic fate of p53-mutant epidermal progenitor cells is tilted toward proliferation by UV B during preneoplasia.Reduction of IKKalpha expression promotes chronic ultraviolet B exposure-induced skin inflammation and carcinogenesisClinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy.Cutaneous field cancerization: clinical, histopathological and therapeutic aspects.Oral feeding of pomegranate fruit extract inhibits early biomarkers of UVB radiation-induced carcinogenesis in SKH-1 hairless mouse epidermisMDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis.p53 mutations as a marker of skin cancer risk: comparison of UVA and UVB effects.Resistance of CD1d-/- mice to ultraviolet-induced skin cancer is associated with increased apoptosis.E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic miceInverse relationship between p53 and phospho-Chk1 (Ser317) protein expression in UVB-induced skin tumors in SKH-1 miceLong noncoding RNA lincRNA-p21 is the major mediator of UVB-induced and p53-dependent apoptosis in keratinocytes.Temporal events in skin injury and the early adaptive responses in ultraviolet-irradiated mouse skin.Loss of Fas-ligand expression in mouse keratinocytes during UV carcinogenesisFrequent clones of p53-mutated keratinocytes in normal human skinSunlight and skin cancer: another link revealedp53 and the pathogenesis of skin cancer.Nucleotide excision repair is reduced in oral epithelial tissues compared with skin.Topical thymidine dinucleotide treatment reduces development of ultraviolet-induced basal cell carcinoma in Ptch-1+/- miceMutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of TaiwanMechanism of UV-related carcinogenesis and its contribution to nevi/melanomaFractionation of a tumor-initiating UV dose introduces DNA damage-retaining cells in hairless mouse skin and renders subsequent TPA-promoted tumors non-regressingp53 tumor suppressor gene: a critical molecular target for UV induction and prevention of skin cancer.Effect of caffeine on UVB-induced carcinogenesis, apoptosis, and the elimination of UVB-induced patches of p53 mutant epidermal cells in SKH-1 mice.Cyclo-oxygenase-2 plays a critical role in UV-induced skin carcinogenesis.Early events in UV carcinogenesis--DNA damage, target cells and mutant p53 foci.UV and pigmentation: molecular mechanisms and social controversies.Celecoxib reduces the effects of acute and chronic UVB exposure in mice treated with therapeutically relevant immunosuppressive drugs.C/EBPalpha is a DNA damage-inducible p53-regulated mediator of the G1 checkpoint in keratinocytes.Chronic low dose UV exposure and p53 mutation: tilting the odds in early epidermal preneoplasia?Current treatment of cutaneous squamous cancer and molecular strategies for its sensitization to new target-based drugs.Milestones in photocarcinogenesis.Crosstalk among p53 family members in cutaneous carcinoma.Modeling cutaneous squamous carcinoma development in the mouseThe absence of Brm exacerbates photocarcinogenesis.Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of 'actinic field damage': recommendations of an international expert group.Ingenol mebutate in the treatment of 'Hydroxyurea-induced Squamous Dysplasia': a single centre experience.
P2860
Q27004135-408E4A37-7A7B-44DA-8754-4DE691D7D2E3Q28594641-9C14EB6D-D25A-4619-98A0-5F7CD0199B3EQ30728582-803A1148-8948-4C2E-BD06-E7D73A996C93Q30835452-3DFD6FC2-8011-47DF-8DAD-C8D495BAD3B5Q33591760-D69371E9-D3D6-43F3-881B-7B57582C1C83Q33816459-02C89011-782B-466B-82A1-100965AB3FA2Q34253991-D0DC279C-3EAA-42EF-A844-776402895D00Q34381303-04A42F96-780D-4BBA-8E2D-3315CD3E50F2Q34467172-DDE2E68B-E714-4936-9DED-5FBE54926E0FQ34489720-5668C80A-02D2-43E8-85EA-B7AA6E392277Q35005696-D8056CAE-0271-4536-BFA8-E8CFFA56DF56Q35103129-9D404F26-9D79-4EDD-999B-55B420DE1117Q35139643-31EEF29B-8422-47EF-991B-F8D88E7CB158Q35195137-D8E4A342-ACDB-4BEB-8094-67EE16F1B3FCQ35274756-74730180-520D-455F-93B9-AAAFAA91811DQ35793451-0128AD91-36CD-44C6-A5B7-82AB1E9D2AC3Q35829735-B510B1C9-6C73-4B8A-AAC1-71857D527915Q35940911-C00C7F1F-1B34-488C-BE32-00B7D02944B2Q36001068-3173C331-AB3E-4FD5-8F1F-DAB2007CB2A0Q36149069-45066037-CA0F-46B5-A5E4-8A1B7B9B4666Q36221422-8BEC9D8A-4E4D-4BA1-8858-6B64F04C6070Q36579806-F8222342-956E-4F25-8F1B-609CF700E68FQ36620304-2370E428-30CB-4929-AA1B-97074689E02EQ36930745-B70149D4-6439-4DBB-8844-A7DFBDD37546Q36946719-B2779245-2F1F-4B91-AC59-C80A62073AF4Q37049524-BA015ECD-63E0-44A5-B8C4-C1FD788B2214Q37052187-2E018CFD-C5A5-4614-9412-22958EC230FFQ37056730-13D5C823-4768-4E92-B10A-1279F3E3EA28Q37067621-9EEDE7A3-DE89-43A4-A858-B71B091338ACQ37281082-972BA506-2E0B-483A-BF79-E09FAFAB5286Q37440010-A9BC0941-0657-491C-9BDE-72469E319ED0Q37683765-5AC5D727-10D3-4774-9108-1EC937A1AB7FQ38016495-415757C4-0CCC-49D0-A00A-ED8185790E41Q38045433-0FF70231-9C1B-4C96-9D71-2317D854CE8FQ38118880-46C98DFA-662C-423B-B3D9-9AF7B17EFC34Q38177887-F8FF3261-8EEF-4930-AFB7-910087E9F521Q38245726-3F24354E-136C-4DE8-8DC9-DADA8AE9F424Q38431688-CC422FE5-AB4E-431F-AE3C-461D6766CAD1Q38629012-4B3FEC66-E7EC-4C4E-B6F1-CCA75602ACD2Q39855397-CE57EB4A-C2C7-491F-91FB-9262375157B5
P2860
Early p53 alterations in mouse skin carcinogenesis by UVB radiation: immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells.
description
1996 nĆ® lÅ«n-bĆ»n
@nan
1996 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« Õ
ÕøÖÕ¶ÕøÖÕ”ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
1996 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ°ÕøÖÕ¶Õ¾Õ”ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
1996幓ć®č«ę
@ja
1996幓č«ę
@yue
1996幓č«ę
@zh-hant
1996幓č«ę
@zh-hk
1996幓č«ę
@zh-mo
1996幓č«ę
@zh-tw
1996幓č®ŗę
@wuu
name
Early p53 alterations in mouse ...... preneoplastic epidermal cells.
@ast
Early p53 alterations in mouse ...... preneoplastic epidermal cells.
@en
type
label
Early p53 alterations in mouse ...... preneoplastic epidermal cells.
@ast
Early p53 alterations in mouse ...... preneoplastic epidermal cells.
@en
prefLabel
Early p53 alterations in mouse ...... preneoplastic epidermal cells.
@ast
Early p53 alterations in mouse ...... preneoplastic epidermal cells.
@en
P2093
P2860
P356
P1476
Early p53 alterations in mouse ...... preneoplastic epidermal cells.
@en
P2093
Van Kreijl CF
de Gruijl FR
de Vries A
van Kranen HJ
van Vloten WA
van der Leun JC
P2860
P304
P356
10.1073/PNAS.93.1.274
P407
P577
1996-01-01T00:00:00Z